FDA Inspection 1154695 — Sophie Piperno-Neumann
The FDA completed an inspection of Sophie Piperno-Neumann on September 17, 2021 in Paris. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 17, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris (France)
Additional Details
Clinical Investigator (CI)